- Large fluctuation in production capacity, energy consumption, and emissions due to new production stages, factory relocation, construction, and product process verification.
- Increased frequency and severity of extreme weather events increasing the risk of power shortages and supply chain disruptions.
- Potential increase in compliance costs due to stricter climate-related regulations.
Dawnrays Pharmaceutical (Holdings) Limited
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Dawnrays Pharmaceutical (Holdings) Limited disclosed greenhouse gas emissions of 42.1K tonnes of carbon dioxide equivalent. By scope: Scope 1: 4.5K tonnes of carbon dioxide equivalent; Scope 2: 37.6K tonnes of carbon dioxide equivalent. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
42.1K tonnes of carbon dioxide equivalent
2023
Water Usage
494.9K m3
2023
Waste
1.1K tonnes
2023
Energy Use
79.1K MWh
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 4.5K tonnes of carbon dioxide equivalent |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 37.6K tonnes of carbon dioxide equivalent |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 42.1K tonnes of carbon dioxide equivalent |
| 2022 | 27.7K tonnes of carbon dioxide equivalent |
| 2019 | 38.3K tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Suzhou Dawnrays Pharma planted 324 trees to offset carbon emissions.
- Suzhou Dawnrays Pharma gradually purchased electric forklifts to replace diesel forklifts.
- Suzhou Dawnrays Pharma added purified water production and wastewater reuse facilities.
- Suzhou Dawnrays Pharma transformed the packaging method of Azithromycin for Suspension, reducing packaging materials consumption by 10% annually.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Reduce GHG emissions, exhaust gas emissions, and hazardous waste intensity gradually in the next five years.
📅 Medium-term
- Achieve emission reduction and waste reduction targets for new production plants and Suzhou & Fujian Dawnrays Pharma.
🔭 Long-term
- Actively cooperate with national policy of “reaching carbon peak by 2030, carbon neutrality by 2060”.
🌱 ESG Focus Areas
EnvironmentalSocialGovernance